Skip to content
MRD Watch

Wednesday, November 18, 2026

Subscribe
Sponsor this briefing. One site and newsletter slot, $250/week.

Briefing

Circulating tumor DNA-guided therapeutic strategies for metastatic colorectal cancer patients with multiple small pulmonary-limited nodules: A prospective cohort study

In this prospective cohort of 70 patients with metastatic colorectal cancer limited to small pulmonary nodules, tumor-informed ctDNA clearance was associated with longer progression-free survival (12.6 vs 6.8 months). ctDNA also flagged extrapulmonary metastases a median of 5.5 months (range 2.8-9.2) before imaging. The authors state that these findings need prospective validation before they are used to guide treatment.

European Journal of CancerPubMed 42962410DOI 10.1016/j.ejca.2026.117793